SUDAPRO

This brand name is authorized in Nigeria.

Active ingredients

The drug SUDAPRO contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4889	Tablet	SUDAPRO TAB 500 mg 1 X 10	61 CMS-PP-245189 SUDAPRO CIPROFLOXACIN HYDROCHLORIDE 500MG Ciprofloxacin Hydrochloride 500mg Maize Starch Microcrystalline Cellulose (PH101) Povidone (PVP K-30) Pregelatinated Starch Methyl Paraben Propyl Paraben Anhydrous Colloidal silicon dioxide (Aerosil 200) Sodium Starch Glycolate Talc Magnesium Stearate Colour con Opadry White Isopropyl Alcohol A4-4889 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 1X10 POM 1 12/16/2021 SUPERIOR PHARMACEUTICALS LIMITED, 9B, ROBINSON GBAGI STREET, AJAO ESTATE 8029403780 superiorpharmang@gmail.com NEROS PHARMACEUTICALS LTD, PLOT 3,NEROS PHARMA AVENUE,KM 38, LAGOS ABEOKUTA EXPRESSWAY,BY SINGER BUSSTOP, SANGO OTA,OGUN STATE,NIGERIA, Nigeria	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-4889